The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
November 27th 2024
Evidence suggests that precautionary measures in elementary schools were able to effectively mitigate large increases in disease transmission.
AAN Names New Editor-in-Chief of Neurology Now Patient Magazine
December 3rd 2014The American Academy of Neurology has named a new editor-in-chief of its award-winning patient education magazine, Neurology Now®. Orly Avitzur, MD, MBA, of Tarrytown, NY, will succeed founding Editor-in-Chief Robin L. Brey, MD, of San Antonio, Texas, who is completing her 10-year term after leading the publication from an idea to a bimonthly magazine with a circulation of 500,000 and a reach of 1.6 million readers.
Read More
Scientists Learn More About the Brain by Studying Harry Potter Readers
December 2nd 2014Chapter 9 of Harry Potter and the Sorcerer's Stone not only hinted at the young wizard's promising future as a Quidditch player, but also helped scientists detect the different brain regions activated among story readers.
Read More
Pharmacist Care Improves Quality of Life in Women with Epilepsy
December 2nd 2014Enrollment in a pharmaceutical care program conducted by a pharmacist can improve health-related quality of life in women with epilepsy, according to a recent study published in Health and Quality of Life Outcomes.
Read More
Roche announced the acquisition of Ariosa Diagnostics, Inc, a privately-held company based in San Jose, California. Ariosa is a molecular diagnostics testing service provider that provides a highly targeted and accurate non-invasive prenatal testing service through their CLIA laboratory using cell-free DNA technology.
Read More
Kmart Pharmacy Takes Step to Battle Methamphetamine Use
December 2nd 2014On the heels of the first national Meth Awareness Week, Kmart Pharmacy announced that all in-store pharmacies nationwide are increasing their efforts to keep their communities safer by stocking NEXAFED®, a meth-resistant pseudoephedrine product designed to help pharmacies and their customers combat methamphetamine usage across the country.
Read More
CDC Approves New Ebola Treatment Centers
December 2nd 2014While there are currently no active cases of Ebola virus infection in the United States, the US Centers for Disease Control and Prevention has announced that 35 hospitals across the country are now designated treatment centers for the virus.
Read More
With flu activity just beginning to rise in many parts of the U.S. in the midst of the busy holiday travel season, Walgreens today introduced its new Flu Index " a weekly report providing state- and market-specific information regarding influenza to help identify areas where flu cases may be escalating. The Index ranks markets and states experiencing the highest incidences of influenza across the country, as well as those showing the largest increases week-over-week.
Read More
NACDS Shifts 2015 NACDS RxIMPACT Day on Capitol Hill to Match Just-Released Congressional Schedule
December 2nd 2014The National Association of Chain Drug Stores has successfully changed the dates and location of its popular and effective NACDS RxIMPACT Day on Capitol Hill, moving the event to March 25 and 26, 2015, at the Marriott Marquis Washington, DC.
Read More
Zohydro ER Deemed Safe, Effective as Long-Term Chronic Pain Treatment
December 2nd 2014A late-stage trial of extended-release hydrocodone bitartrate (Zohydro ER) pointed to a generally safe and well-tolerated response among patients with chronic pain for up to 1 year, according to Zogenix, Inc.
Read More
Gingrich Sees Potential for "Bitter, Brutal Fight" Between GOP and White House
December 2nd 2014Former House Speaker Newt Gingrich today told senior health care executives at an Academy of Managed Care Pharmacy forum that Congressional Republicans are weighing whether to "get into the death grip of Obamacare" or to wait out President Obama's term seeking "specific, practical, doable reforms."
Read More
Mylan, Inc, announced that its subsidiary Mylan Laboratories Limited has entered into an agreement with Gilead Sciences, Inc, under which Mylan has licensed the non-exclusive rights to manufacture and distribute Tenofovir Alafenamide as both a single agent product and in combination with other drugs.
Read More